Table 1.
Demographic and preoperative characteristics
| Variable | Group (median) | Q1–Q3 | Range |
|---|---|---|---|
| Age (years) | 61 | 56–65 | 40–76 |
|
| |||
| BMI | 27.0 | 25.1–29.6 | 17.4–50.5 |
|
| |||
| Preoperative PSA (ng/mL) | 5.5 | 4.3–7.5 | 0.5–68.0 |
|
| |||
| TRUS prostate volume (mL) | 36 | 28–46 | 12–149 |
|
| |||
| IPSS | 6 | 3–11 | 0–35 |
|
| |||
| SHIM | 21 | 16–24 | 0–25 |
|
| |||
| Biopsy Gleason score | Frequency (n=712) | Rate | |
|
| |||
| 6 | 246 | 34.6% | |
| 7 | 411 | 57.7% | |
| 8 | 43 | 6.0% | |
| 9 | 12 | 1.7% | |
|
| |||
| Clinical TNM stage | Frequency (n=700) | Rate | |
|
| |||
| T1a/1b | 3 | 0.4% | |
| T1c | 490 | 70.0% | |
| T2a | 186 | 26.6% | |
| T2b | 17 | 2.4% | |
| T3 | 4 | 0.6% | |
BMI: body mass index; PSA: prostate-specific antigen; TRUS: transrectal ultrasound; IPSS: International Prostate Symptoms Score; SHIM: Sexual Health Inventory for Men.